Related Experiment Video
Updated: Aug 29, 2025
09:15
A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
Published on: February 28, 2019
11.9K
An optimized mouse model of Staphylococcus aureus infected diabetic ulcers
Ana Isabel Mendes1,2, Maria João Peixoto1,2, Alexandra Pinto Marques2,3
1School of Medicine, Life and Health Sciences Research Institute (ICVS), University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
BMC Research Notes
|September 7, 2022
Summary
Researchers developed an optimized mouse model for diabetic foot infections (DFI) using methicillin-resistant Staphylococcus aureus (MRSA). This model effectively mimics DFI features, aiding the study of new antimicrobial therapies for this challenging condition.
Area of Science:
- Infectious Diseases
- Diabetology
- Wound Healing Research
Background:
- Diabetic foot infections (DFI) pose a significant healthcare challenge due to diabetes-related complications and rising antimicrobial resistance.
- Effective treatment of DFI is hindered by complex pathophysiology and the emergence of resistant pathogens.
- Novel therapeutic strategies are urgently needed to combat DFI.
Purpose of the Study:
- To develop and optimize a preclinical mouse model for studying diabetic foot infections.
- To create a reliable model that recapitulates key pathological features of human DFI.
- To provide a suitable platform for evaluating new treatments against methicillin-resistant Staphylococcus aureus (MRSA) in a diabetic context.
Main Methods:
- Establishment of a diabetic mouse model.
- Infection of wounds with methicillin-resistant Staphylococcus aureus (MRSA).
- Optimization of techniques for disease induction and assessment.
Main Results:
- The developed model successfully mimics critical DFI characteristics, including pathogen invasion, necrosis, and persistent inflammation.
- Impaired wound healing was observed, consistent with clinical DFI presentations.
- The model allows for time-efficient and straightforward evaluation of therapeutic interventions.
Conclusions:
- This optimized diabetic mouse model provides a valuable tool for investigating DFI pathogenesis and treatment.
- It serves as a robust platform for preclinical testing of novel therapies against MRSA-DFI.
- The model facilitates research into effective management strategies for diabetic foot infections.
